The University of Edinburgh
Role of infections, cigarette smoke and cytokines in the pathogenesis of chronic obstructive pulmonary disease
Abstract
dc:description.abstractChronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. The precise sequence of events in COPD is not completely understood. Inflammation in the airways has been unanimously seen by researchers as a pivotal factor, and cigarette smoking without doubt is the main cause. Large proportions of heavy smokers, however, do not suffer with COPD, suggesting a role of additional risk factors, e.g., respiratory tract infections, in pathogenesis. The inflammatory response to cigarette smoke and infectious agents is determined by the host's genetic make up. Cigarette smoking, by altering the surface milieu of respiratory mucosa and by causing immunosuppression increases the susceptibility of individuals to infection with respiratory viral and bacterial pathogens. Virus infection has also been recognized as a susceptibility factor for secondary bacterial infection. An investigation into the role of individual genetic variations in inflammatory cell and cytokine production and non-host factors involved in COPD is the basis for development of more effective strategies to intervene in pathogenesis, progression and exacerbation of COPD. The aims of this work was to review the evidence for predisposing factors for COPD, with a particular emphasis on respiratory tract infections, and to examine those findings in relation to individual genetic variations and their interactions for induction of pro-inflammatory cytokine production in the respiratory tract. In vitro models were developed to measure cytokine responses to various agents implicated in COPD. These examined the interaction, antagonistic, indifferent, additive or synergistic, between cigarette smoke and infectious agents or their products on cytokine production. Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis and respiratory syncytial virus are common bacterial and viral pathogens isolated from this group of patients. A human monocyte cell line in a model provided a consistent means to examine these interactions, and human peripheral blood monocytes from blood donors were used to study the individual variations in the responses. Effects of virus infection on bactericidal activity of human monocytes common bacterial respiratory pathogens were also examined. An epithelial cell line and monocytes were investigated for the effects due to virus infection on expression of some of the surface antigens relevant to bacterial binding and immune response. The agents used in the study elicited inflammatory responses that could contribute to damage to the respiratory tract and these individual factors could be more harmful in combination. Monocytes from only a proportion of individuals exhibited extreme responses to these agents signifying the role of individual genetic make up in inflammatory processes. Virus-infected monocytes significantly decreased their ability to bind and kill bacteria. Compared with uninfected cells, fewer bacteria bound to virus-infected cells and intracellular bactericidal activity was also decreased. Virus-infected epithelial cells expressed more surface antigens that have been reported to bind respiratory tract bacterial pathogens, while virus-infected monocytes expressed these antigens at lower levels, which offered an explanation to their decreased bacterial binding and bactericidal activity. These experimental findings, taken together with the review of the literature presented in this work, suggested that exposure to a number of harmful factors for longer periods in individuals with certain genetic profiles for inflammation may cause significant damage to the respiratory tract resulting in COPD, and exacerbation in its course. Further work to examine the individual genetic make up and inflammatory cytokines in a population of patients with COPD compared with non-COPD smokers would be required to substantiate this hypothesis before investigating the possibility of therapeutic interventions to restrain or modify inflammatory process in COPD.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2006
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Raza, Muhammad Waqar
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/33642